University Hospital Heidelberg – Germany
About Prof. Andreas Kulozik
Prof. Dr. med. Andreas Kulozik, PhD is an internationally renowned Pediatric Oncologist and Hematologist with 39+ years of clinical and research experience. Since 2001, he has been Medical Director of the Department of Pediatric Oncology, Hematology, Immunology and Pulmonology at Heidelberg University Hospital (UKHD), and since 2016, Director of the Clinical Pediatric Oncology Program at the Hopp Children’s Cancer Center (KiTZ), NCT Heidelberg. His department treats 1,500+ pediatric cancer and severe blood-disease patients every year and is a pioneering facility in Germany. He is widely regarded as one of the leading Pediatric Oncologist specialists in Heidelberg, Germany for international families seeking expert pediatric cancer care.
- 39+ years of clinical and research experience in pediatric hematology and oncology
- Medical Director — Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital (UKHD) (since 2001)
- Director, Clinical Pediatric Oncology Program — Hopp Children’s Cancer Center (KiTZ) at NCT Heidelberg (since 2016)
- Co-Director — Molecular Medicine Partnership Unit (MMPU), Heidelberg University Medical Faculty & EMBL (since 2002)
- Head, Clinical Cooperation Unit “Pediatric Leukemias” — German Cancer Research Center (DKFZ)
- 293 scientific publications; Elected Member EMBO and German National Academy of Sciences Leopoldina
Qualifications & Credentials
Medical Degrees
- Studies in Human Medicine (Graduation) — Universities of Münster, Germany and Glasgow, United Kingdom, 1974–1984
- MD (Dr. med.) — University of Münster, Germany, 1985
- PhD — MRC Molecular Haematology Unit, University of Oxford, United Kingdom, 1987
- Specialist Certification (Facharzt) — Pediatrics and Adolescent Medicine, Germany
Fellowships & Special Training
- Sub-specialty training: Pediatric Hematology & Oncology, Pediatric Intensive Care Medicine, Stem-Cell Transplantation, Pediatric Pneumology — Germany
- Continuing professional development in personalised medicine, gene therapy and rare anemias / hemoglobinopathies
Certifications & Accreditations
- Baden-Württemberg State Medical Council — Registered Specialist (Facharzt) in Pediatrics & Adolescent Medicine
- Sub-specialty certifications: Pediatric Hematology & Oncology, Pediatric Intensive Care, Stem-Cell Transplantation, Pediatric Pneumology
- Elected Member, European Molecular Biology Organization (EMBO)
- Elected Member, German National Academy of Sciences Leopoldina
Areas of Expertise
Major Conditions Treated
- Childhood Acute Lymphoblastic Leukaemia (ALL) & Acute Myeloid Leukaemia (AML)
- Hodgkin and Non-Hodgkin Lymphomas in Children
- Solid Tumours: Ewing Sarcoma, Osteosarcoma, Neuroblastoma, Rhabdomyosarcoma, Nephroblastoma (Wilms Tumour)
- Pediatric Brain Tumours (Coordinated with Pediatric Neuro-Oncology)
- Bleeding Disorders & Coagulation Diseases in Children
- Rare Anaemias and Hemoglobin Disorders (Thalassaemia, Sickle Cell Disease)
- Primary Immunodeficiencies
- Pediatric Pulmonology Conditions including Cystic Fibrosis
- Pediatric Intensive Care
Sub-specialties
- Personalised Pediatric Oncology & Pediatric Leukaemias: Head, Forschergruppe Kulozik “Personalisierte Medizin in der Pädiatrischen Onkologie” and Head, DKFZ CCU Pediatric Leukemias — making him a leading Pediatric Oncologist specialist Heidelberg, Germany for personalised pediatric oncology.
- Stem-Cell Transplantation, Cell & Gene Therapy: Medical Director of the Pediatric Oncology & Stem-Cell Transplantation Ward (Station K3) and the special outpatient clinic for Gene Therapy — supporting demand for the best Pediatric Oncologist doctor in Germany for cell and gene therapy.
- Hemoglobinopathies & Pediatric Hematology: Special outpatient clinics for rare anaemias, hemoglobin disorders (thalassaemia, sickle cell), bleeding disorders and primary immunodeficiencies.
Advanced Procedures & Treatments
- Pediatric Chemotherapy & Targeted Therapy
- Pediatric Immunotherapy & CAR-T Cell Therapy Coordination
- Autologous & Allogeneic Hematopoietic Stem-Cell Transplantation
- Gene Therapy for Pediatric Hematological Diseases
- Personalised, Biomarker-Guided Pediatric Oncology Therapy
- Multidisciplinary Pediatric Tumour Board Assessments
- Bleeding Disorders & Coagulation Workup
- Management of Thalassaemia & Sickle Cell Disease
- Pediatric Intensive Care
- Clinical Trials for Pediatric Cancers
List of Disease and Treatment for which Prof. Andreas Kulozik can be consulted
Professional Experience
Current Affiliation
- Medical Director — Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, University Hospital Heidelberg (UKHD), Angelika Lautenschläger Children’s Hospital, Im Neuenheimer Feld 430, D-69120 Heidelberg (since 2001 – Present)
- Director, Clinical Pediatric Oncology Program — Hopp Children’s Cancer Center (KiTZ), NCT Heidelberg (since 2016 – Present)
- Co-Director — Molecular Medicine Partnership Unit (MMPU), Heidelberg University Medical Faculty & EMBL, Im Neuenheimer Feld 350, 69120 Heidelberg (since 2002 – Present)
- Head, Clinical Cooperation Unit “Pediatric Leukemias” — German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg (Present)
- Head, Forschergruppe Kulozik “Personalisierte Medizin in der Pädiatrischen Onkologie” (Present)
- Medical Director, Pediatric Oncology Ward & Stem-Cell Transplantation (Station K3-Onkologie) (Present)
Past Affiliations
- University of Oxford, MRC Molecular Haematology Unit — PhD Research Fellow, 1985–1987
- University of Münster, Germany — MD Research, 1984–1985
- Universities of Münster (Germany) and Glasgow (UK) — Medical Studies, 1974–1984
Academic & Research Roles
- Univ.-Prof. of Pediatric Oncology, Hematology and Immunology — Medical Faculty Heidelberg, Heidelberg University
- Member of the KiTZ Directorate (with Prof. Dr. Olaf Witt and Prof. Dr. Stefan Pfister)
- Author of 293 peer-reviewed scientific publications
- Elected Member, EMBO & Leopoldina (German National Academy of Sciences)
- Active mentor for clinician-scientists and PhD candidates at UKHD, KiTZ and DKFZ
Key Achievements
- Founding Director of the Clinical Pediatric Oncology Program at KiTZ — one of Europe’s leading pediatric oncology centres
- Department under his leadership treats 1,500+ pediatric cancer and severe blood-disease patients yearly
- Co-Founder of the Molecular Medicine Partnership Unit (MMPU) between UKHD and EMBL
- Pioneer of personalised medicine in pediatric oncology in Germany
- Elected to EMBO and the Leopoldina German National Academy of Sciences
Awards & Recognitions
National & International Awards
- Elected Member, European Molecular Biology Organization (EMBO)
- Elected Member, German National Academy of Sciences Leopoldina
Professional Memberships
- European Molecular Biology Organization (EMBO) — Elected Member
- German National Academy of Sciences Leopoldina — Elected Member
- Society for Pediatric Oncology and Hematology (GPOH)
- European Society for Paediatric Oncology (SIOPE)
- American Society of Hematology (ASH)
- European Hematology Association (EHA)
- German Society for Hematology & Medical Oncology (DGHO)
Research & Publications
Published Papers (Selected)
- Kulozik AE, et al. Detection of Bone Marrow Involvement in Children with Hodgkin’s Lymphoma.
- Kulozik AE, et al. Treatment of Relapsed Lymphoid Disease with T Lymphocytes — Pediatric Cell & Gene Therapy.
- Kulozik AE, et al. Impact of Gender on the Efficacy of Chemotherapy in Ewing Sarcoma.
- Kulozik AE, et al. Personalised Medicine in Pediatric Oncology — Strategies of the Forschergruppe Kulozik.
- Kulozik AE, et al. Pediatric Leukaemias — DKFZ Clinical Cooperation Unit Reports.
- Total of 293 peer-reviewed scientific publications across pediatric hematology, oncology, molecular medicine, hemoglobinopathies and gene therapy.
Ongoing Research & Clinical Interests
- Personalised medicine in pediatric oncology
- Pediatric leukaemias and lymphomas
- Pediatric stem-cell transplantation, cell & gene therapy
- Rare anaemias and hemoglobin disorders (thalassaemia, sickle cell)
- Pediatric solid tumours (Ewing, osteosarcoma, neuroblastoma, rhabdomyosarcoma, nephroblastoma)
- Molecular medicine partnership with EMBL
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (EUR) | Estimated Cost (USD) |
|---|---|---|
| Pediatric Oncology Consultation | €350 – €700 | $380 – $760 |
| Multidisciplinary Pediatric Tumour Board Review | €700 – €1,800 | $760 – $1,960 |
| Comprehensive Molecular Tumour Profiling | €2,500 – €6,000 | $2,700 – $6,500 |
| Pediatric Chemotherapy (per cycle) | €2,500 – €8,000 | $2,700 – $8,700 |
| Pediatric Targeted / Immunotherapy (per month) | €5,000 – €15,000 | $5,400 – $16,300 |
| Autologous Stem-Cell Transplantation (Pediatric) | €80,000 – €150,000 | $87,000 – $163,000 |
| Allogeneic Stem-Cell Transplantation (Pediatric) | €150,000 – €300,000 | $163,000 – $326,000 |
| Pediatric CAR-T Cell Therapy (per course) | €280,000 – €350,000 | $304,000 – $380,000 |
| Gene Therapy for Hemoglobinopathies (indicative) | €600,000 – €1,800,000 | $650,000 – $1,950,000 |
| Inpatient Pediatric Oncology Stay (per day) | €800 – €1,800 | $870 – $1,960 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. med. Andreas Kulozik, PhD use in Pediatric Oncologist treatment?
Prof. Dr. med. Andreas Kulozik, PhD employs the latest evidence-based tools and minimally invasive techniques relevant to Pediatric Oncologist. Virtual consultations and remote second opinions are also available to international patients. Contact Cancer Rounds for a detailed technology overview specific to your case.
2. What conditions does Prof. Dr. med. Andreas Kulozik, PhD specialize in treating?
Prof. Dr. med. Andreas Kulozik, PhD is a specialist in Pediatric Oncologist, treating a broad spectrum of conditions in this field — including both common presentations and complex, rare cases. International patients seek treatment for conditions requiring expert Pediatric Oncologist care in Heidelberg, Germany.
3. How do I book an appointment with Prof. Dr. med. Andreas Kulozik, PhD?
Appointments with Prof. Dr. med. Andreas Kulozik, PhD can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. med. Andreas Kulozik, PhD?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. med. Andreas Kulozik, PhD, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. med. Andreas Kulozik, PhD offer second opinions for Pediatric Oncologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Pediatric Oncologist specialist in Heidelberg, Germany.
University Hospital Heidelberg - Germany
